Table 1 Comparison of demographic and clinical characteristics among groups

No. (%) with data

489 (61.7)

124 (15.6)

90 (11.3)

90 (11.3)

Age, months

39.0 [12.0–88.0]

22.5 [5.0–52.8]^a

23.5 [4.0–106.0]

14.0 [2.0–97.5]^a

Body weight, kg

14.5 [9.5–25.3]

12.0 [6.8–16.9]^a

13.0 [6.2–27.0]

10.0 [5.2–22.1]^a

Male, n

298 (60.9)

75 (60.5)

59 (65.6)

52 (57.8)

PRISM III, score

3 [2–6]

7 [2–11]^a

8 [2–12.3]^a

12 [6.8–19.3]^a,b,c

pSOFA, score

2 [1–4]

3 [1–5]^a

5 [3–7]^a,b

7 [4–12]^a,b,c

Sepsis, n

49 (10.0)

20 (16.1)

22 (24.4)^a

38 (42.2)^a,b,c

MV, n

142 (29.0)

35 (28.2)

46 (51.1)^a,b

52 (57.8)^a,b

MV duration, hours

0 [0–5]

0 [0–31.5]

1 [0–158.8]^a,b

23 [0–140.3]^a,b

Inotrope, n

38 (7.8)

21 (16.9)^a

30 (33.3)^a,b

38 (42.2)^a,b

Furosemide. n

130 (26.6)

37 (29.8)

54 (60.0)^a,b

43 (47.8)^a,b

Steroid, n

195 (39.9)

49 (39.5)

47 (52.2)^a

35 (38.9)

PICU length of stay, day

5 (3–9)

6 (3–9)

7 (4–18.3)^a,b

5 (2.8–10.3)^c

PICU Mortality, n

16 (3.3)

12 (9.7)^a

13 (14.4)^a

29 (32.2)^{a, b, c}

30-day PICU Mortality, n

14 (2.9)

12 (9.7)^a

12 (13.3)^a

28 (31.1)^{a, b, c}

 < 0.001